HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $16 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.3%

Neg 0% Neu 88.3% Pos 0%

HC Wainwright & Co. analyst Douglas Tsao reiterates Cabaletta Bio (NASDAQ:CABA) with a Buy and maintains $16 price target.